Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Viruses 14.2 (2022): 284.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Reuter, Nina
Kropff, Barbara
Britt, William J.
Mach, Michael
Thomas, Marco
- DOI
-
10.3390/v14020284
- URN
-
urn:nbn:de:bvb:29-opus4-183720
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reuter, Nina
- Kropff, Barbara
- Britt, William J.
- Mach, Michael
- Thomas, Marco
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Advancing single cell and multiplex cloning strategies to identify broadly neutralizing antibodies targeting infectious pathogens
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Neutralizing antibodies as tools for structure-based vaccine design
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Advancing single cell and multiplex cloning strategies to identify broadly neutralizing antibodies targeting infectious pathogens
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Neutralizing antibodies as tools for structure-based vaccine design
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Advancing single cell and multiplex cloning strategies to identify broadly neutralizing antibodies targeting infectious pathogens
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Neutralizing antibodies as tools for structure-based vaccine design